Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Neumann

Showing results (31-40 of 118) with videos related to

Pageof 12
Sort By:
Cancer Immunology, Immunotherapy : CII|August 23, 2018
Determination of optimum vitamin D3 levels for NK cell-mediated rituximab- and obinutuzumab-dependent cellular cytotoxicityFrank Neumann, Fabian Acker, Claudia Schormann, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 9, 2021
SARS-CoV-2 vaccination in cardiothoracic organ transplant recipients: effective strategies wantedSebastian Ewen, Frank Neumann, Jörg T Bittenbring, et al.
Blood|November 16, 2002
Hodgkin and Reed-Sternberg cell-associated autoantigen CLIP-170/restin is a marker for dendritic cells and is involved in the trafficking of macropinosomes to the cytoskeleton, supporting a function-based concept of Hodgkin and Reed-Sternberg cellsUgur Sahin, Frank Neumann, Ozlem Tureci, et al.
Atherosclerosis|August 31, 2015
A novel small molecule TLR4 antagonist (IAXO-102) negatively regulates non-hematopoietic toll like receptor 4 signalling and inhibits aortic aneurysms developmentChristopher Huggins, Stuart Pearce, Francesco Peri, et al.
Innate Immunity|September 14, 2018
The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signallingCharys Palmer, Francesco Peri, Frank Neumann, et al.
Cancer Immunology, Immunotherapy : CII|January 28, 2004
Identification of an antigenic peptide derived from the cancer-testis antigen NY-ESO-1 binding to a broad range of HLA-DR subtypesFrank Neumann, Claudia Wagner, Boris Kubuschok, et al.
Evolutionary Computation|July 30, 2025
Illuminating the Diversity-Fitness Trade-Off in Black-Box OptimizationMaria Laura Santoni, Elena Raponi, Aneta Neumann, et al.
Anesthesia and Analgesia|March 26, 2004
Perioperative intravenous lidocaine has preventive effects on postoperative pain and morphine consumption after major abdominal surgeryWolfgang Koppert, Marc Weigand, Frank Neumann, et al.
Expert Opinion on Drug Discovery|March 20, 2013
Sense and sensibility: the use of cell death biomarker assays in high-throughput anticancer drug screening and monitoring treatment responsesMaria C Shoshan, Associate Professor Principal Investigator Aleksandra Mandic Havelka, Frank Neumann, et al.
Innate Immunity|April 16, 2021
Synthetic glycolipid-based TLR4 antagonists negatively regulate TRIF-dependent TLR4 signalling in human macrophagesCharys Palmer, Fabio A Facchini, Richard Po Jones, et al.
Pageof 12

Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
Cancer Immunology, Immunotherapy : CII|August 23, 2018
Determination of optimum vitamin D3 levels for NK cell-mediated rituximab- and obinutuzumab-dependent cellular cytotoxicityFrank Neumann, Fabian Acker, Claudia Schormann, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 9, 2021
SARS-CoV-2 vaccination in cardiothoracic organ transplant recipients: effective strategies wantedSebastian Ewen, Frank Neumann, Jörg T Bittenbring, et al.
Blood|November 16, 2002
Hodgkin and Reed-Sternberg cell-associated autoantigen CLIP-170/restin is a marker for dendritic cells and is involved in the trafficking of macropinosomes to the cytoskeleton, supporting a function-based concept of Hodgkin and Reed-Sternberg cellsUgur Sahin, Frank Neumann, Ozlem Tureci, et al.
Atherosclerosis|August 31, 2015
A novel small molecule TLR4 antagonist (IAXO-102) negatively regulates non-hematopoietic toll like receptor 4 signalling and inhibits aortic aneurysms developmentChristopher Huggins, Stuart Pearce, Francesco Peri, et al.
Innate Immunity|September 14, 2018
The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signallingCharys Palmer, Francesco Peri, Frank Neumann, et al.
Cancer Immunology, Immunotherapy : CII|January 28, 2004
Identification of an antigenic peptide derived from the cancer-testis antigen NY-ESO-1 binding to a broad range of HLA-DR subtypesFrank Neumann, Claudia Wagner, Boris Kubuschok, et al.
Evolutionary Computation|July 30, 2025
Illuminating the Diversity-Fitness Trade-Off in Black-Box OptimizationMaria Laura Santoni, Elena Raponi, Aneta Neumann, et al.
Anesthesia and Analgesia|March 26, 2004
Perioperative intravenous lidocaine has preventive effects on postoperative pain and morphine consumption after major abdominal surgeryWolfgang Koppert, Marc Weigand, Frank Neumann, et al.
Expert Opinion on Drug Discovery|March 20, 2013
Sense and sensibility: the use of cell death biomarker assays in high-throughput anticancer drug screening and monitoring treatment responsesMaria C Shoshan, Associate Professor Principal Investigator Aleksandra Mandic Havelka, Frank Neumann, et al.
Innate Immunity|April 16, 2021
Synthetic glycolipid-based TLR4 antagonists negatively regulate TRIF-dependent TLR4 signalling in human macrophagesCharys Palmer, Fabio A Facchini, Richard Po Jones, et al.
Pageof 12